Death of a 29-Year-Old Male from Undifferentiated Sepsis

Tumour necrosis factor alpha inhibitors, such as infliximab, and other biologic agents are associated with increased risk of opportunistic infection, including tuberculosis. Tuberculosis infections associated with infliximab tend to present atypically and can be difficult to diagnose, as they are mo...

Full description

Saved in:
Bibliographic Details
Main Authors: Kathryn A. Trebuss, Samantha Buttemer, Jeffrey S. Wilkinson, Josie Xu, John P. Rossiter, Kieran M. Moore
Format: Article
Language:English
Published: Wiley 2016-01-01
Series:Canadian Journal of Infectious Diseases and Medical Microbiology
Online Access:http://dx.doi.org/10.1155/2016/2478924
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832556020072710144
author Kathryn A. Trebuss
Samantha Buttemer
Jeffrey S. Wilkinson
Josie Xu
John P. Rossiter
Kieran M. Moore
author_facet Kathryn A. Trebuss
Samantha Buttemer
Jeffrey S. Wilkinson
Josie Xu
John P. Rossiter
Kieran M. Moore
author_sort Kathryn A. Trebuss
collection DOAJ
description Tumour necrosis factor alpha inhibitors, such as infliximab, and other biologic agents are associated with increased risk of opportunistic infection, including tuberculosis. Tuberculosis infections associated with infliximab tend to present atypically and can be difficult to diagnose, as they are more likely to manifest as extrapulmonary or disseminated disease. The authors report a case involving a 29-year-old male patient who died following 16 days of treatment for undifferentiated sepsis and who was found on autopsy to have widespread disseminated tuberculosis. Prior to the onset of illness, the patient had received infliximab for the treatment of Crohn’s disease. Following discussion of the case, the authors review the definition of adverse events, provide a root cause analysis of the cognitive errors and breakdowns in the health care system that contributed to the reported outcome, and identify opportunities to address these breakdowns and improve patient safety measures for future cases.
format Article
id doaj-art-cc5e5b1805a74b79a438f8fad77773de
institution Kabale University
issn 1712-9532
1918-1493
language English
publishDate 2016-01-01
publisher Wiley
record_format Article
series Canadian Journal of Infectious Diseases and Medical Microbiology
spelling doaj-art-cc5e5b1805a74b79a438f8fad77773de2025-02-03T05:46:37ZengWileyCanadian Journal of Infectious Diseases and Medical Microbiology1712-95321918-14932016-01-01201610.1155/2016/24789242478924Death of a 29-Year-Old Male from Undifferentiated SepsisKathryn A. Trebuss0Samantha Buttemer1Jeffrey S. Wilkinson2Josie Xu3John P. Rossiter4Kieran M. Moore5Queen’s University, Kingston, ON, K7L 3N6, CanadaQueen’s University, Kingston, ON, K7L 3N6, CanadaQueen’s University, Kingston, ON, K7L 3N6, CanadaUniversity of Toronto, Toronto, ON, M5S 1A8, CanadaDepartment of Pathology and Molecular Medicine, Queen’s University and Kingston General Hospital, Kingston, ON, K7L 3N6, CanadaDepartment of Family Medicine and Emergency Medicine, Queen’s University, Kingston, ON, K7L 3N6, CanadaTumour necrosis factor alpha inhibitors, such as infliximab, and other biologic agents are associated with increased risk of opportunistic infection, including tuberculosis. Tuberculosis infections associated with infliximab tend to present atypically and can be difficult to diagnose, as they are more likely to manifest as extrapulmonary or disseminated disease. The authors report a case involving a 29-year-old male patient who died following 16 days of treatment for undifferentiated sepsis and who was found on autopsy to have widespread disseminated tuberculosis. Prior to the onset of illness, the patient had received infliximab for the treatment of Crohn’s disease. Following discussion of the case, the authors review the definition of adverse events, provide a root cause analysis of the cognitive errors and breakdowns in the health care system that contributed to the reported outcome, and identify opportunities to address these breakdowns and improve patient safety measures for future cases.http://dx.doi.org/10.1155/2016/2478924
spellingShingle Kathryn A. Trebuss
Samantha Buttemer
Jeffrey S. Wilkinson
Josie Xu
John P. Rossiter
Kieran M. Moore
Death of a 29-Year-Old Male from Undifferentiated Sepsis
Canadian Journal of Infectious Diseases and Medical Microbiology
title Death of a 29-Year-Old Male from Undifferentiated Sepsis
title_full Death of a 29-Year-Old Male from Undifferentiated Sepsis
title_fullStr Death of a 29-Year-Old Male from Undifferentiated Sepsis
title_full_unstemmed Death of a 29-Year-Old Male from Undifferentiated Sepsis
title_short Death of a 29-Year-Old Male from Undifferentiated Sepsis
title_sort death of a 29 year old male from undifferentiated sepsis
url http://dx.doi.org/10.1155/2016/2478924
work_keys_str_mv AT kathrynatrebuss deathofa29yearoldmalefromundifferentiatedsepsis
AT samanthabuttemer deathofa29yearoldmalefromundifferentiatedsepsis
AT jeffreyswilkinson deathofa29yearoldmalefromundifferentiatedsepsis
AT josiexu deathofa29yearoldmalefromundifferentiatedsepsis
AT johnprossiter deathofa29yearoldmalefromundifferentiatedsepsis
AT kieranmmoore deathofa29yearoldmalefromundifferentiatedsepsis